Electroacupuncture Anesthesia for Nasal Sinus Surgery and Mammaplasty
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01700855 |
Recruitment Status :
Completed
First Posted : October 4, 2012
Last Update Posted : July 11, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Therapeutic (Nonsurgical) and Rehabilitative Anesthesiology Devices Associated With Adverse Incidents | Procedure: non-electroacupuncture Procedure: Electroacupuncture | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 137 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Investigator, Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Electroacupuncture for Pain Relief in Patients With Nasal Sinus Surgery and Mammaplasty: a Randomized Controlled Study |
Study Start Date : | June 2012 |
Actual Primary Completion Date : | November 2012 |
Actual Study Completion Date : | December 2012 |

Arm | Intervention/treatment |
---|---|
Experimental: Electroacupuncture
Patients received electroacupuncture stimulation
|
Procedure: Electroacupuncture
Electrodes are applied to bilateral "Hegu(L14)" acupoints at the time of 1h before operation, and connected to Hwato Electronic Acupuncture Treatment Instrument (Model No. SDZ-V, Suzhou Medical Appliances Co., Ltd., Suzhou, China). The acupoints are stimulated at an intensity of 3~6 mA and a frequency of 2/30 Hz for 30 min. The highest intensity will be chosen at which the patient can tolerate.
Other Names:
|
Sham Comparator: Non-electroacupuncture
Patients received sham electroacupuncture
|
Procedure: non-electroacupuncture
The same procedure as electroacupuncture except stimulation
Other Name: Sham |
- the mean infusion rate of intraoperative remifentanil and propofol [ Time Frame: during operation ]To investigate the operative time and total volume of remifentanil and propofol used during operation, and then calculate the mean infusion rate. To assess whether intraoperative requirements for anesthetic drugs could be reduced by EA pretreatment.
- Visual analogue scale [ Time Frame: post-operative 4h, 8h, 24h and 48h ]To assess whether EA pretreatment could help in alleviating acute post-operative pain.
- Extubation time [ Time Frame: postoperation ]To investigate the time from the end of propofol and remifentanil infusion to extubation. To assess whether EA pretreatment could shorten the extubation time.
- plasma β-endorphin and cortisol concentration [ Time Frame: preoperation, 0h and 24h postoperation ]To assess whether EA pretreatment could increase the plasma levels of β-endorphin and cortisol.
- Ramsay score [ Time Frame: post-operative 4h, 8h, 24h, 48h ]To assess the effect of EA pretreatment on post-operative Ramsay scores.
- incidence of post-operative nausea and vomiting (PONV) [ Time Frame: within post-operative 24 hours ]To assess the effect of EA pretreatment on PONV.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 29 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- selective nasal sinus surgery
- selective mammaplasty
- patients who accept the follow-up and sign the informed consent
- ASA 1~2
Exclusion Criteria:
- emergent surgery
- pregnant or breast-feeding women
- coagulopathy
- history of gastrointestinal ulcer
- liver or renal dysfunction
- enrollment in other clinical trials at the same time not reaching the primary endpoint and probably interference the present trial

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01700855
China, Shaanxi | |
Xijing Hospital | |
Xi'an, Shaanxi, China, 710032 |
Study Director: | Qiang Wang, M.D., Ph.D. | Xijing Hospital |
Responsible Party: | wangqiang, Associate Professor, Associate Consultant, Xijing Hospital |
ClinicalTrials.gov Identifier: | NCT01700855 |
Other Study ID Numbers: |
mazuike-28 |
First Posted: | October 4, 2012 Key Record Dates |
Last Update Posted: | July 11, 2014 |
Last Verified: | May 2012 |
Electroacupuncture Analgesia Anesthesia Nasal septoplasty Mammaplasty |